Hypothesis

Intermittent hormetic stressors (e.g., fasting, exercise) trigger a NAD+-dependent SIRT1 deacetylation cascade that silences BCL-2 transcription through heterochromatin formation at its promoter, creating a self‑sustaining low‑BCL-2 state that maintains elevated autophagy even after the stressor is withdrawn.

Mechanistic Rationale

• Hormetic spikes raise intracellular NAD+, activating SIRT1, which deacetylates histone H3 lysines at the BCL-2 promoter, facilitating recruitment of SUV39H1 and deposition of H3K9me3 repressive marks [SIRT1 deacetylates BCL-2 promoter][NAD+-SIRT1 link][H3K9me3 mediated silencing].
• Reduced BCL-2 lessens its sequestration of Beclin-1 at the ER, permitting constitutive VPS34/Class III PI3K complex assembly and basal autophagy flux [BCL-2/Beclin-1 interaction].
• This epigenetic lock mirrors the constitutive autophagy seen in Beclin-1 F121A knock‑in mice, where lifespan extension occurs without continuous threat signaling [F121A lifespan extension].
• Unlike transient post‑translational modifications, DNA‑methylation and histone‑methylation can persist through cell divisions, providing a molecular memory that outlasts the original hormetic cue.

Testable Predictions

1. Persistence of low BCL-2 – After a defined period of intermittent fasting (IF) washout, liver and muscle tissues will show significantly reduced BCL-2 mRNA and protein levels compared with ad libitum controls, correlating with increased H3K9me3 at the BCL-2 promoter.
2. Autophagy flux maintenance – LC3‑II turnover and p62 degradation will remain elevated in washed‑out IF animals, indicating sustained autophagic activity independent of ongoing stress.
3. Dependency on SIRT1 – Liver‑specific SIRT1 knockout mice subjected to the same IF regimen will fail to develop the repressive chromatin mark, will not suppress BCL-2, and will show autophagy levels that return to baseline after stressor removal.
4. Phenotypic outcome – Wild‑type mice undergoing IF followed by washout will exhibit extended median lifespan and improved healthspan markers (reduced tumorigenesis, cardiac fibrosis) only if the SIRT1‑dependent epigenetic silencing occurs; SIRT1‑deficient counterparts will not.

Experimental Design

• Group 1: Wild‑type C57BL/6 mice subjected to 24‑hour IF cycles twice weekly for 3 months, then returned to ad libitum feeding for 2 months (washout).
• Group 2: Littermate controls fed ad libitum throughout.
• Group 3: Liver‑specific SIRT1 knockout mice undergoing identical IF/washout protocol.
• Endpoints (collected at washout completion):
  • qPCR and Western blot for BCL-2, Beclin-1, LC3‑I/II, p62.
  • ChIP‑qPCR for H3K9me3 and SIRT1 occupancy at the BCL-2 promoter.
  • Autophagy flux assay using lysosomal inhibitor (chloroquine) chase.
  • Survival monitoring and healthspan assessments (echocardiography, histopathology, glucose tolerance).

Falsification – If BCL-2 levels rebound to baseline after washout despite prior IF, or if SIRT1 loss does not prevent BCL-2 suppression, the hypothesis that hormesis creates a durable epigenetic autophagy switch would be refuted, supporting the view that hormetic benefits require continuous threat signaling.

By linking hormetic NAD+ flux to a self‑reinforcing chromatin state, this hypothesis bridges the gap between transient stress responses and the persistent autophagy upregulation demonstrated by genetic models, offering a concrete, falsifiable route to test whether cells can indeed retain a ‘peaceful’ pro‑longevity program after the danger signal has faded.